Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis
Personlig udvikling
Many parents of children with serious health problems may wonder why new medicines are initially not approved for minors and, if their condition is rare, why at the same time there is such pressure to enter any young person under 18 into drug trials. So-called 'paediatric' pharmaceutical studies have become an international multi-billion business with many careers in academia, regulatory authorities and the pharmaceutical industry based on this work, yet much of this activity is founded on a series of flawed concepts that have led to immeasurable wastage of resources and serious, ongoing medical abuse. In this revelatory book, the former head of paediatric drug research at two major pharmaceutical companies provides a guide for parents and non-specialists interested in advancing the health of individual children and groups of children showing the key differences between clinically-directed and administratively-directed research, what will potentially benefit or harm children and how the law needs to change around the world so that true advances can be made.
© 2022 Hammersmith Health Books (E-bog): 9781781612033
Release date
E-bog: 6. januar 2022
Over 600.000 titler
Download og nyd titler offline
Eksklusive titler + Mofibo Originals
Børnevenligt miljø (Kids Mode)
Det er nemt at opsige når som helst
For dig som vil prøve Mofibo.
1 konto
20 timer/måned
Eksklusivt indhold hver uge
Fri lytning til podcasts
Gem ubrugt tid
Ingen binding
For dig som lytter og læser ofte.
1 konto
100 timer/måned
Eksklusivt indhold hver uge
Fri lytning til podcasts
Ingen binding
For dig som lytter og læser ubegrænset.
1 konto
Ubegrænset adgang
Eksklusivt indhold hver uge
Fri lytning til podcasts
Ingen binding
For dig som ønsker at dele historier med familien.
2-6 konti
100 timer/måned pr. konto
Fri lytning til podcasts
Kun 39 kr. pr. ekstra konto
Ingen binding
2 konti
179 kr. /månedDansk
Danmark